Cytori Therapeutics reported $-5120000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US $ 351M 188M
Cytori Therapeutics CYTX:US $ -5120000 1.19M
Dr.Reddys Laboratories DRRD:IN 6.39B 4.81B
Genocea Biosciences GNCA:US $ -15.77M 2.36M
Haemonetics HAE:US $ 30.77M 11.57M
Infinity Pharmaceuticals INFI:US $ -12.02M 0.39M
Merrimack Pharmaceuticals MACK:US $ -486000 354K
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Northwest Biotherapeutics NWBO:US -21209000 9.33M
Starpharma Holdings Ltd SPL:AU -7705000 744K
Sun Pharmaceuticals SUNP:IN IR 21507.2M 44635.9M
Teva Pharmaceutical TEVA:IT -949000000 236M